Exeter Financial’s Clorox CLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-2,117
Closed -$213K 99
2025
Q4
$213K Sell
2,117
-3,569
-63% -$387K 0.09% 95
2025
Q3
$701K Sell
5,686
-600
-10% -$74.5K 0.3% 70
2025
Q2
$755K Sell
6,286
-1,743
-22% -$233K 0.34% 66
2025
Q1
$1.18M Buy
8,029
+43
+0.5% +$6.57K 0.53% 59
2024
Q4
$1.3M Buy
7,986
+199
+3% +$32.6K 0.59% 53
2024
Q3
$1.27M Sell
7,787
-2,279
-23% -$338K 0.56% 55
2024
Q2
$1.37M Sell
10,066
-7
-0.1% -$972 0.66% 50
2024
Q1
$1.48M Buy
10,073
+1,425
+16% +$213K 0.68% 51
2023
Q4
$1.22M Sell
8,648
-391
-4% -$52.1K 0.59% 53
2023
Q3
$1.18M Buy
9,039
+441
+5% +$67K 0.62% 52
2023
Q2
$1.33M Buy
8,598
+48
+0.6% +$7.74K 0.69% 47
2023
Q1
$1.35M Sell
8,550
-740
-8% -$111K 0.68% 51
2022
Q4
$1.31M Sell
9,290
-204
-2% -$29K 0.68% 54
2022
Q3
$1.23M Sell
9,494
-109
-1% -$15.7K 0.71% 52
2022
Q2
$1.35M Buy
9,603
+218
+2% +$31.1K 0.76% 50
2022
Q1
$1.3M Buy
9,385
+1,131
+14% +$173K 0.71% 50
2021
Q4
$1.48M Sell
8,254
-821
-9% -$137K 0.81% 46
2021
Q3
$1.5M Buy
9,075
+215
+2% +$37K 0.9% 44
2021
Q2
$1.59M Buy
8,860
+509
+6% +$92.9K 0.92% 42
2021
Q1
$1.61M Buy
8,351
+327
+4% +$62.9K 1.02% 37
2020
Q4
$1.62M Buy
8,024
+151
+2% +$31.2K 1.12% 34
2020
Q3
$1.66M Buy
7,873
+26
+0.3% +$5.79K 1.29% 30
2020
Q2
$1.72M Sell
7,847
-44
-0.6% -$8.79K 1.43% 25
2020
Q1
$1.37M Sell
7,891
-1,329
-14% -$220K 1.28% 31
2019
Q4
$1.42M Buy
9,220
+11
+0.1% +$1.64K 1.1% 40
2019
Q3
$1.4M Sell
9,209
-91
-1% -$14.4K 1.11% 38
2019
Q2
$1.42M Sell
9,300
-296
-3% -$45.2K 1.19% 37
2019
Q1
$1.54M Buy
9,596
+43
+0.5% +$6.67K 1.33% 30
2018
Q4
$1.47M Sell
9,553
-77
-0.8% -$12K 1.39% 30
2018
Q3
$1.45M Sell
9,630
-89
-0.9% -$12.6K 1.19% 33
2018
Q2
$1.31M Buy
9,719
+367
+4% +$45.3K 1.16% 35
2018
Q1
$1.25M Buy
9,352
+2,290
+32% +$308K 1.07% 37
2017
Q4
$1.05M Buy
+7,062
New +$961K 0.92% 41

Other funds holding CLX

Exeter Financial's CLX Position: Q1 2026 in Review

Exeter Financial sold out of Clorox (CLX) in Q1 2026, closing a stake of 2,117 shares — an estimated $213K sold.

Exeter Financial first reported a position in CLX in Q4 2017 and held it in 33 quarters. The position peaked at $1.72M in Q2 2020. 1,081 funds tracked by Wall St. Rank hold CLX as of Q1 2026.

  • Exeter Financial reported no remaining Clorox position as of Q1 2026 after selling out during the quarter.
  • Exeter Financial sold 2,117 Clorox shares in Q1 2026, an estimated $213K.
  • Exeter Financial first reported a position in Clorox in Q4 2017 and held it in 33 quarters.
  • Exeter Financial's Clorox position peaked at $1.72M in Q2 2020.
  • 1,081 funds tracked by Wall St. Rank held Clorox as of Q1 2026.

Based on Exeter Financial's 13F filing for Q1 2026, filed 23 Apr 2026.